Lissenzis Sachets (for Acne)

Product Highlights & Key Claims

• Ranked No. 1 (Saccharomyces cerevisiae) systemic formulation (in Germany*) for treating acne. S. cerevisiae (Lissenzis) is approved by Commission E for the treatment of acne.
• Used in highly developed countries (in EU) for more than 70 years, launched for the first time in India by Prazis Healthcare Private Limited.
• Recent advancements in medical research confirm that acne is not just a skin disease. Acne is caused by disturbances in the gut-bran-skin axis which leads to proliferation of C. acne, increased sebum production and substance P.
• Current therapy approaches offer only symptomatic relief, they cannot completely cure acne because they do not address the root cause (disturbances in the gut-bran-skin axis).
• Current treatment approaches in acne disrupt the integrity of skin barrier and cause irritation, stinging, dryness, dysbiosis of the skin and trans-epidermal water loss.
• These conventional medications actually lead to aggravation of symptoms, because they further worsen the already disturbed gut-brain-skin axis in acne patients.
• Lissenzis corrects the gut-brain-skin axis, thereby treats the root cause of acne.
• Lissenzis is highly effective, and a valuable agent in the treatment of acne.
• Safe, no side effects unlike conventional therapies.
• S. cerecisiae is US FDA GRAS certified.
• After completing the course (1 month), Lissenzis effectively relieves the symptoms.

Please read the enclosed patient information leaflet (contains directions for use, precautions etc.) before using the product.

*Book on German Commission E monographs